Bio-Based Cosmetics & Personal Care Ingredients Market by Ingredient Classification (Amino Acids, Enzymes, Fatty Acids), Source (Algae & Marine, Animal Derivatives, Microbial Fermentation), Form, Distribution Channel, Application - Global Forecast 2025-20
Description
The Bio-Based Cosmetics & Personal Care Ingredients Market was valued at USD 2.13 billion in 2024 and is projected to grow to USD 2.36 billion in 2025, with a CAGR of 11.08%, reaching USD 4.95 billion by 2032.
A concise orientation to bio-based cosmetics and personal care ingredients that frames innovation, sustainability, and commercial dynamics for executive decision-making
The executive summary frames a rapidly evolving ecosystem where bio-based cosmetics and personal care ingredients are moving from niche sustainability claims to foundational elements of product differentiation. Innovation in feedstocks and bioprocessing is expanding the palette of functional ingredients available to formulators, while rising consumer expectations and emerging regulatory requirements are redefining what constitutes acceptable supply chain practices. This introduction sets the scene by articulating how scientific advances, changing procurement philosophies, and strategic partnerships are collectively shaping opportunities and risks for manufacturers, ingredient suppliers, and brand owners.
Across categories, stakeholders are recalibrating priorities: chemists and formulators must reconcile performance and sensory expectations with biodegradability and regulatory compliance; procurement teams must balance supply resilience against cost volatility and traceability demands; and marketing functions must translate technical credentials into credible consumer narratives. Collectively, these forces create an imperative for leaders to adopt integrated strategies that span R&D, sourcing, and commercialization. This section provides a concise orientation to those dynamics, emphasizing the interplay between technology maturity, consumer acceptance, and policy drivers without presuming uniform adoption timelines across product categories.
How scientific breakthroughs, consumer values, regulatory pressure, and supply chain redesign are reshaping the competitive landscape for bio-based personal care ingredients
The landscape for bio-based personal care ingredients is being reshaped by a confluence of technological advances, evolving consumer values, and regulatory momentum. Breakthroughs in synthetic biology and precision fermentation are enabling the production of complex molecules with lower land and water footprints, thereby expanding the functional scope of bio-based alternatives beyond commodity replacements to performance-enhancing actives. At the same time, consumers are demonstrating greater discernment, seeking transparent provenance, clean-label narratives, and verifiable sustainability claims, which in turn pressures brands to source ingredients that can be authenticated across the supply chain.
Regulatory environments are tightening in parallel, with jurisdictions introducing more stringent definitions around claims such as natural, bio-based, and biodegradable. Consequently, manufacturers and suppliers are investing in traceability systems and third-party validation schemes to preserve market access. Additionally, supply chain redesign-characterized by nearshoring, dual sourcing, and strategic inventories-is becoming a strategic response to both geopolitical uncertainty and the need for ingredient traceability. Together, these shifts necessitate that organizations re-evaluate R&D portfolios, supplier partnerships, and commercial narratives to remain competitive while meeting heightened expectations from regulators, retailers, and consumers.
Assessing the cumulative effects of United States tariff policy shifts in 2025 on sourcing, cost structures, and strategic sourcing choices across bio-based cosmetic ingredient supply chains
The tariff measures implemented in 2025 have a layered effect on the sourcing economics, supplier selection, and strategic posture of organizations engaged in bio-based ingredient supply chains. Tariffs increase landed costs for some imported feedstocks and finished ingredients, which incentivizes buyers to reexamine origin diversification, supplier qualification criteria, and long-term contracting strategies. As a consequence, procurement teams are shifting from lowest-cost sourcing to a more nuanced calculus that weighs geopolitical risk, carbon footprint, lead time variability, and supplier transparency.
In response to tariff-induced cost pressures, some suppliers are accelerating regional manufacturing investments to mitigate customs exposure and shorten logistics chains. Others are entering contractual hedges or co-investment arrangements with downstream brands to secure stable volumes and to share margin pressure. Meanwhile, innovation pathways are adapting: formulators are prioritizing locally abundant raw materials and platform technologies such as microbial fermentation that can be deployed in multiple geographies. Importantly, tariffs also act as a catalyst for vertical collaboration between ingredient producers and manufacturers, prompting joint risk sharing and product co-development to preserve margin and meet compliance requirements. These dynamics underscore the need for near-term tactical responses and longer-term strategic shifts to maintain product competitiveness and supply resilience.
Segment-level clarity revealing application use cases, ingredient classifications, functional roles, source origins, formulation forms, and distribution pathways driving product strategies
Deep segmentation reveals differentiated demand signals and technical requirements across product segments that should guide portfolio and commercialization strategies. Based on Application, market coverage ranges from Baby Care to Bath & Shower, Color Cosmetics to Deodorants, Fragrance to Hair Care, Oral Care to Skin Care, each presenting distinct safety, sensory, and regulatory constraints that influence ingredient selection and claim architecture. Based on Ingredient Classification, stakeholders engage with families such as Amino Acids, Enzymes, Fatty Acids, Lipids & Oils, Organic Acids, Polysaccharides, Proteins & Peptides, Sterols, and Vitamins, where development cycles and process complexity vary significantly and dictate partnership needs and capital intensity.
Based on Function, ingredients perform roles including Antioxidants, Cleansing Agents, Emollients, Emulsifiers, Humectants, Preservatives, Surfactants, and UV Filters, and functional performance must be validated in target matrices to achieve parity with conventional chemistries. Based on Source, the supply base spans Algae & Marine inputs, Animal Derivatives, Microbial Fermentation outputs, Plant Derivatives, and Synthetic Biology products, and each source carries different sustainability narratives and regulatory scrutiny. Based on Form, formulations range from Cream and Emulsion to Gel, Liquid, Oil, and Powder, influencing processing and packaging considerations. Based on Distribution Channel, market dynamics diverge between Offline and Online pathways, affecting speed-to-market and marketing approaches. Together, these segmentation layers inform product prioritization, go-to-market sequencing, and technical validation roadmaps for both suppliers and brands.
Regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence sourcing, innovation hubs, and regulatory pathways for ingredients
Regional behavior exhibits pronounced variation driven by policy, academic ecosystems, and industrial capability. In the Americas, strong consumer demand for sustainability credentials is paired with advanced biotechnology clusters and venture activity that accelerate scale-up of fermentation-derived actives. Regulatory frameworks emphasize labeling transparency and claim substantiation, prompting companies to invest in traceability systems and lifecycle assessments. Consequently, North American and Latin American supply chains demonstrate a mix of innovative scale-ups and established raw material exporters that collaborate to serve both mass and prestige segments.
Europe, Middle East & Africa displays heightened regulatory stringency and early adoption of circularity mandates, which favors ingredient suppliers that can demonstrate rigorous environmental data and compliance track records. European markets also host substantial ingredient R&D and pilot-scale fermentation facilities, incentivizing higher technical integration between suppliers and brands. In the Asia-Pacific region, manufacturing scale and diverse botanical resources provide a competitive cost base and a fast follower market dynamic; however, regulatory harmonization is uneven across the region, which requires tailored market access strategies. Across regions, the combination of local innovation capacity, regulatory posture, and consumer sentiment shapes where companies choose to develop, produce, and commercialize new bio-based ingredient solutions.
Competitive intelligence on incumbent suppliers, emerging startups, and strategic partnerships that are accelerating commercialization of bio-based ingredients and formulation innovation
Competitive dynamics are characterized by a balance between incumbent chemical suppliers, specialized bio-based ingredient companies, and a growing cohort of biotechnology startups. Incumbents leverage distribution scale, regulatory experience, and customer relationships to integrate bio-based options into existing portfolios, often through targeted acquisitions or strategic joint ventures. Specialized suppliers focus on high-value niches where technical differentiation and IP protection support premium positioning, while startups accelerate novel pathways through agile development cycles and close collaboration with lead brands. Across these segments, strategic partnerships between ingredient developers and multinational brands are emerging as a preferred commercialization model because they align R&D focus with guaranteed demand and shared risk.
Corporate strategies increasingly emphasize modular manufacturing, licensing of platform technologies, and creation of co-development vehicles to accelerate market entry. At the same time, investors and corporate venturing units are prioritizing companies that demonstrate scalable process economics, robust regulatory roadmaps, and defensible sustainability credentials. Companies that excel in analytical validation, traceability platforms, and cross-functional commercialization capabilities tend to capture early adoption in premium segments, while those that standardize production and optimize unit costs are positioned to serve mass-market applications. The overall competitive landscape therefore favors firms that can combine technical rigor with clear go-to-market execution plans.
Action-oriented guidance for manufacturers, ingredient suppliers, retailers, and regulators to translate sustainability, resilience, and commercial opportunity into measurable business outcomes
Industry leaders should pursue a set of coordinated actions that align R&D, procurement, and commercial functions to capture both sustainability value and market share. First, establishing clear technical performance targets that map to product claims will allow R&D teams to prioritize projects with the highest commercial potential and to design validation protocols that resonate with regulators and retailers. Second, diversifying sourcing strategies through regional dual-sourcing, strategic inventories, and supplier co-investment reduces exposure to trade friction while preserving speed to market. Third, investing in traceability and third-party verification will protect brand equity and facilitate market access as regulatory scrutiny intensifies.
Moreover, firms should consider deploying modular manufacturing and licensing partnerships to accelerate scale-up without incurring disproportionate capital risk. Collaborative models-such as co-development agreements and off-take arrangements-can align incentives across the value chain and expedite commercialization. Commercial teams must also refine messaging to combine technical substantiation with consumer-relevant benefits, and digital channels should be leveraged to accelerate trial and feedback cycles. Finally, senior leadership should integrate scenario planning into strategic reviews to stress-test assumptions about tariffs, raw material availability, and regulatory shifts, ensuring agility in reallocating investments as market signals evolve.
Robust and transparent research methodology combining primary interviews, technical validation, supply chain mapping, and triangulated secondary research to ensure analytical rigor
The research methodology combines primary qualitative interviews, technical literature review, and supply chain mapping to produce a transparent and defensible analytical framework. Primary inputs include structured interviews with R&D leads, procurement executives, regulatory specialists, and independent formulation experts, which are used to ground-truth thematic hypotheses and capture real-world constraints. Secondary inputs comprise peer-reviewed scientific literature, patent filings, regulatory publications, and publicly available sustainability disclosures, which provide technical context and historical precedent for technology adoption paths.
Analytical rigor is reinforced through triangulation of multiple data streams and scenario analysis to explore alternative outcomes under differing policy and supply conditions. Technical validation steps include laboratory confirmation of functional claims when feasible and expert panel reviews to evaluate methodological assumptions. Supply chain mapping techniques identify critical nodes, chokepoints, and traceability gaps, while risk matrices are developed to prioritize mitigation efforts. Finally, the methodology documents sources and confidence levels for each finding to enable clients to assess the strength of evidence supporting strategic recommendations.
Consolidated conclusions synthesizing technological, regulatory, and market-facing signals to guide senior leaders in prioritizing investments and strategic roadmaps for bio-based ingredients
The synthesis highlights a clear inflection point: technological maturity and consumer expectations have converged to make bio-based ingredients a strategic priority rather than a niche marketing tactic. Leaders who act decisively-by aligning R&D priorities with validated functional performance, diversifying supply chains to mitigate geopolitical and tariff risks, and investing in traceability and verification-will be better positioned to capture value as acceptance grows. Conversely, organizations that treat the transition as a peripheral sustainability exercise risk being outpaced on both product performance and regulatory compliance.
Looking forward, success will hinge on integrated strategies that unite technical excellence with commercial discipline. Companies should prioritize scalable platform technologies, form strategic partnerships for de-risked scale-up, and apply disciplined scenario planning to prepare for policy shifts and supply disruptions. By doing so, they can convert sustainability imperatives into durable competitive advantages and build product portfolios that meet tomorrow’s regulatory and consumer expectations without compromising performance or profitability.
Note: PDF & Excel + Online Access - 1 Year
A concise orientation to bio-based cosmetics and personal care ingredients that frames innovation, sustainability, and commercial dynamics for executive decision-making
The executive summary frames a rapidly evolving ecosystem where bio-based cosmetics and personal care ingredients are moving from niche sustainability claims to foundational elements of product differentiation. Innovation in feedstocks and bioprocessing is expanding the palette of functional ingredients available to formulators, while rising consumer expectations and emerging regulatory requirements are redefining what constitutes acceptable supply chain practices. This introduction sets the scene by articulating how scientific advances, changing procurement philosophies, and strategic partnerships are collectively shaping opportunities and risks for manufacturers, ingredient suppliers, and brand owners.
Across categories, stakeholders are recalibrating priorities: chemists and formulators must reconcile performance and sensory expectations with biodegradability and regulatory compliance; procurement teams must balance supply resilience against cost volatility and traceability demands; and marketing functions must translate technical credentials into credible consumer narratives. Collectively, these forces create an imperative for leaders to adopt integrated strategies that span R&D, sourcing, and commercialization. This section provides a concise orientation to those dynamics, emphasizing the interplay between technology maturity, consumer acceptance, and policy drivers without presuming uniform adoption timelines across product categories.
How scientific breakthroughs, consumer values, regulatory pressure, and supply chain redesign are reshaping the competitive landscape for bio-based personal care ingredients
The landscape for bio-based personal care ingredients is being reshaped by a confluence of technological advances, evolving consumer values, and regulatory momentum. Breakthroughs in synthetic biology and precision fermentation are enabling the production of complex molecules with lower land and water footprints, thereby expanding the functional scope of bio-based alternatives beyond commodity replacements to performance-enhancing actives. At the same time, consumers are demonstrating greater discernment, seeking transparent provenance, clean-label narratives, and verifiable sustainability claims, which in turn pressures brands to source ingredients that can be authenticated across the supply chain.
Regulatory environments are tightening in parallel, with jurisdictions introducing more stringent definitions around claims such as natural, bio-based, and biodegradable. Consequently, manufacturers and suppliers are investing in traceability systems and third-party validation schemes to preserve market access. Additionally, supply chain redesign-characterized by nearshoring, dual sourcing, and strategic inventories-is becoming a strategic response to both geopolitical uncertainty and the need for ingredient traceability. Together, these shifts necessitate that organizations re-evaluate R&D portfolios, supplier partnerships, and commercial narratives to remain competitive while meeting heightened expectations from regulators, retailers, and consumers.
Assessing the cumulative effects of United States tariff policy shifts in 2025 on sourcing, cost structures, and strategic sourcing choices across bio-based cosmetic ingredient supply chains
The tariff measures implemented in 2025 have a layered effect on the sourcing economics, supplier selection, and strategic posture of organizations engaged in bio-based ingredient supply chains. Tariffs increase landed costs for some imported feedstocks and finished ingredients, which incentivizes buyers to reexamine origin diversification, supplier qualification criteria, and long-term contracting strategies. As a consequence, procurement teams are shifting from lowest-cost sourcing to a more nuanced calculus that weighs geopolitical risk, carbon footprint, lead time variability, and supplier transparency.
In response to tariff-induced cost pressures, some suppliers are accelerating regional manufacturing investments to mitigate customs exposure and shorten logistics chains. Others are entering contractual hedges or co-investment arrangements with downstream brands to secure stable volumes and to share margin pressure. Meanwhile, innovation pathways are adapting: formulators are prioritizing locally abundant raw materials and platform technologies such as microbial fermentation that can be deployed in multiple geographies. Importantly, tariffs also act as a catalyst for vertical collaboration between ingredient producers and manufacturers, prompting joint risk sharing and product co-development to preserve margin and meet compliance requirements. These dynamics underscore the need for near-term tactical responses and longer-term strategic shifts to maintain product competitiveness and supply resilience.
Segment-level clarity revealing application use cases, ingredient classifications, functional roles, source origins, formulation forms, and distribution pathways driving product strategies
Deep segmentation reveals differentiated demand signals and technical requirements across product segments that should guide portfolio and commercialization strategies. Based on Application, market coverage ranges from Baby Care to Bath & Shower, Color Cosmetics to Deodorants, Fragrance to Hair Care, Oral Care to Skin Care, each presenting distinct safety, sensory, and regulatory constraints that influence ingredient selection and claim architecture. Based on Ingredient Classification, stakeholders engage with families such as Amino Acids, Enzymes, Fatty Acids, Lipids & Oils, Organic Acids, Polysaccharides, Proteins & Peptides, Sterols, and Vitamins, where development cycles and process complexity vary significantly and dictate partnership needs and capital intensity.
Based on Function, ingredients perform roles including Antioxidants, Cleansing Agents, Emollients, Emulsifiers, Humectants, Preservatives, Surfactants, and UV Filters, and functional performance must be validated in target matrices to achieve parity with conventional chemistries. Based on Source, the supply base spans Algae & Marine inputs, Animal Derivatives, Microbial Fermentation outputs, Plant Derivatives, and Synthetic Biology products, and each source carries different sustainability narratives and regulatory scrutiny. Based on Form, formulations range from Cream and Emulsion to Gel, Liquid, Oil, and Powder, influencing processing and packaging considerations. Based on Distribution Channel, market dynamics diverge between Offline and Online pathways, affecting speed-to-market and marketing approaches. Together, these segmentation layers inform product prioritization, go-to-market sequencing, and technical validation roadmaps for both suppliers and brands.
Regional dynamics and strategic implications across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence sourcing, innovation hubs, and regulatory pathways for ingredients
Regional behavior exhibits pronounced variation driven by policy, academic ecosystems, and industrial capability. In the Americas, strong consumer demand for sustainability credentials is paired with advanced biotechnology clusters and venture activity that accelerate scale-up of fermentation-derived actives. Regulatory frameworks emphasize labeling transparency and claim substantiation, prompting companies to invest in traceability systems and lifecycle assessments. Consequently, North American and Latin American supply chains demonstrate a mix of innovative scale-ups and established raw material exporters that collaborate to serve both mass and prestige segments.
Europe, Middle East & Africa displays heightened regulatory stringency and early adoption of circularity mandates, which favors ingredient suppliers that can demonstrate rigorous environmental data and compliance track records. European markets also host substantial ingredient R&D and pilot-scale fermentation facilities, incentivizing higher technical integration between suppliers and brands. In the Asia-Pacific region, manufacturing scale and diverse botanical resources provide a competitive cost base and a fast follower market dynamic; however, regulatory harmonization is uneven across the region, which requires tailored market access strategies. Across regions, the combination of local innovation capacity, regulatory posture, and consumer sentiment shapes where companies choose to develop, produce, and commercialize new bio-based ingredient solutions.
Competitive intelligence on incumbent suppliers, emerging startups, and strategic partnerships that are accelerating commercialization of bio-based ingredients and formulation innovation
Competitive dynamics are characterized by a balance between incumbent chemical suppliers, specialized bio-based ingredient companies, and a growing cohort of biotechnology startups. Incumbents leverage distribution scale, regulatory experience, and customer relationships to integrate bio-based options into existing portfolios, often through targeted acquisitions or strategic joint ventures. Specialized suppliers focus on high-value niches where technical differentiation and IP protection support premium positioning, while startups accelerate novel pathways through agile development cycles and close collaboration with lead brands. Across these segments, strategic partnerships between ingredient developers and multinational brands are emerging as a preferred commercialization model because they align R&D focus with guaranteed demand and shared risk.
Corporate strategies increasingly emphasize modular manufacturing, licensing of platform technologies, and creation of co-development vehicles to accelerate market entry. At the same time, investors and corporate venturing units are prioritizing companies that demonstrate scalable process economics, robust regulatory roadmaps, and defensible sustainability credentials. Companies that excel in analytical validation, traceability platforms, and cross-functional commercialization capabilities tend to capture early adoption in premium segments, while those that standardize production and optimize unit costs are positioned to serve mass-market applications. The overall competitive landscape therefore favors firms that can combine technical rigor with clear go-to-market execution plans.
Action-oriented guidance for manufacturers, ingredient suppliers, retailers, and regulators to translate sustainability, resilience, and commercial opportunity into measurable business outcomes
Industry leaders should pursue a set of coordinated actions that align R&D, procurement, and commercial functions to capture both sustainability value and market share. First, establishing clear technical performance targets that map to product claims will allow R&D teams to prioritize projects with the highest commercial potential and to design validation protocols that resonate with regulators and retailers. Second, diversifying sourcing strategies through regional dual-sourcing, strategic inventories, and supplier co-investment reduces exposure to trade friction while preserving speed to market. Third, investing in traceability and third-party verification will protect brand equity and facilitate market access as regulatory scrutiny intensifies.
Moreover, firms should consider deploying modular manufacturing and licensing partnerships to accelerate scale-up without incurring disproportionate capital risk. Collaborative models-such as co-development agreements and off-take arrangements-can align incentives across the value chain and expedite commercialization. Commercial teams must also refine messaging to combine technical substantiation with consumer-relevant benefits, and digital channels should be leveraged to accelerate trial and feedback cycles. Finally, senior leadership should integrate scenario planning into strategic reviews to stress-test assumptions about tariffs, raw material availability, and regulatory shifts, ensuring agility in reallocating investments as market signals evolve.
Robust and transparent research methodology combining primary interviews, technical validation, supply chain mapping, and triangulated secondary research to ensure analytical rigor
The research methodology combines primary qualitative interviews, technical literature review, and supply chain mapping to produce a transparent and defensible analytical framework. Primary inputs include structured interviews with R&D leads, procurement executives, regulatory specialists, and independent formulation experts, which are used to ground-truth thematic hypotheses and capture real-world constraints. Secondary inputs comprise peer-reviewed scientific literature, patent filings, regulatory publications, and publicly available sustainability disclosures, which provide technical context and historical precedent for technology adoption paths.
Analytical rigor is reinforced through triangulation of multiple data streams and scenario analysis to explore alternative outcomes under differing policy and supply conditions. Technical validation steps include laboratory confirmation of functional claims when feasible and expert panel reviews to evaluate methodological assumptions. Supply chain mapping techniques identify critical nodes, chokepoints, and traceability gaps, while risk matrices are developed to prioritize mitigation efforts. Finally, the methodology documents sources and confidence levels for each finding to enable clients to assess the strength of evidence supporting strategic recommendations.
Consolidated conclusions synthesizing technological, regulatory, and market-facing signals to guide senior leaders in prioritizing investments and strategic roadmaps for bio-based ingredients
The synthesis highlights a clear inflection point: technological maturity and consumer expectations have converged to make bio-based ingredients a strategic priority rather than a niche marketing tactic. Leaders who act decisively-by aligning R&D priorities with validated functional performance, diversifying supply chains to mitigate geopolitical and tariff risks, and investing in traceability and verification-will be better positioned to capture value as acceptance grows. Conversely, organizations that treat the transition as a peripheral sustainability exercise risk being outpaced on both product performance and regulatory compliance.
Looking forward, success will hinge on integrated strategies that unite technical excellence with commercial discipline. Companies should prioritize scalable platform technologies, form strategic partnerships for de-risked scale-up, and apply disciplined scenario planning to prepare for policy shifts and supply disruptions. By doing so, they can convert sustainability imperatives into durable competitive advantages and build product portfolios that meet tomorrow’s regulatory and consumer expectations without compromising performance or profitability.
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
191 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Commercial adoption of microbial fermentation to produce high-purity hyaluronic acid for skincare
- 5.2. Development of algae-derived bioactive pigments as sustainable colorants in personal care products
- 5.3. Upscaling agricultural by-product upcycling to extract plant-based peptides for anti-aging formulations
- 5.4. Use of insect-sourced chitin and chitosan from black soldier fly for biodegradable cosmetic exfoliants
- 5.5. Integration of encapsulated botanical extracts from plant cell cultures for targeted skin delivery systems
- 5.6. Implementation of green surfactants derived from sugar fermentation as eco-friendly cleansing agents
- 5.7. Adoption of lactic acid bacterial fermentation to create natural preservatives for clean beauty products
- 5.8. Commercial-scale production of squalane through yeast fermentation as sustainable emollient alternative
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Bio-Based Cosmetics & Personal Care Ingredients Market, by Ingredient Classification
- 8.1. Amino Acids
- 8.2. Enzymes
- 8.3. Fatty Acids
- 8.4. Lipids & Oils
- 8.5. Organic Acids
- 8.6. Polysaccharides
- 8.7. Proteins & Peptides
- 8.8. Sterols
- 8.9. Vitamins
- 9. Bio-Based Cosmetics & Personal Care Ingredients Market, by Source
- 9.1. Algae & Marine
- 9.2. Animal Derivatives
- 9.3. Microbial Fermentation
- 9.4. Plant Derivatives
- 9.5. Synthetic Biology
- 10. Bio-Based Cosmetics & Personal Care Ingredients Market, by Form
- 10.1. Cream
- 10.2. Emulsion
- 10.3. Gel
- 10.4. Liquid
- 10.5. Oil
- 10.6. Powder
- 11. Bio-Based Cosmetics & Personal Care Ingredients Market, by Distribution Channel
- 11.1. Offline
- 11.2. Online
- 12. Bio-Based Cosmetics & Personal Care Ingredients Market, by Application
- 12.1. Baby Care
- 12.2. Bath & Shower
- 12.3. Color Cosmetics
- 12.4. Deodorants
- 12.5. Fragrance
- 12.6. Hair Care
- 12.7. Oral Care
- 12.8. Skin Care
- 13. Bio-Based Cosmetics & Personal Care Ingredients Market, by Region
- 13.1. Americas
- 13.1.1. North America
- 13.1.2. Latin America
- 13.2. Europe, Middle East & Africa
- 13.2.1. Europe
- 13.2.2. Middle East
- 13.2.3. Africa
- 13.3. Asia-Pacific
- 14. Bio-Based Cosmetics & Personal Care Ingredients Market, by Group
- 14.1. ASEAN
- 14.2. GCC
- 14.3. European Union
- 14.4. BRICS
- 14.5. G7
- 14.6. NATO
- 15. Bio-Based Cosmetics & Personal Care Ingredients Market, by Country
- 15.1. United States
- 15.2. Canada
- 15.3. Mexico
- 15.4. Brazil
- 15.5. United Kingdom
- 15.6. Germany
- 15.7. France
- 15.8. Russia
- 15.9. Italy
- 15.10. Spain
- 15.11. China
- 15.12. India
- 15.13. Japan
- 15.14. Australia
- 15.15. South Korea
- 16. Competitive Landscape
- 16.1. Market Share Analysis, 2024
- 16.2. FPNV Positioning Matrix, 2024
- 16.3. Competitive Analysis
- 16.3.1. Akzo Nobel N.V.
- 16.3.2. Ashland Global Holdings Inc.
- 16.3.3. BASF SE
- 16.3.4. Clariant AG
- 16.3.5. Croda International Plc
- 16.3.6. Dow Inc.
- 16.3.7. DuPont de Nemours Inc.
- 16.3.8. Eastman Chemical Company
- 16.3.9. Evonik Industries AG
- 16.3.10. Firmenich SA
- 16.3.11. Genomatica, Inc.
- 16.3.12. Givaudan S.A.
- 16.3.13. Inolex, Inc.
- 16.3.14. Kao Corporation
- 16.3.15. Lonza Group Ltd.
- 16.3.16. Nouryon
- 16.3.17. Seppic S.A.
- 16.3.18. Sollice Biotech, Inc.
- 16.3.19. Solvay S.A.
- 16.3.20. Symrise AG
- 16.3.21. The Lubrizol Corporation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
